Lorotox, ear drops 1%+4% 16 g

Otitis

Local symptomatic treatment and analgesia in children from birth and adults for otitis media with intact tympanic membrane, including:

• acute exudative middle otitis;
• otitis as a complication of influenza, exudative viral otitis;
• barotraumatic otitis media.

If necessary, consult a doctor before using the medicine.

Indications

Local symptomatic treatment and pain relief in children from birth and adults with otitis media with an intact eardrum, including:

acute exudative otitis media;
otitis as a complication after influenza, exudative viral otitis;
barotraumatic otitis.

If necessary, consult your doctor before using this medicine.

Pharmacological effect

Phenazone has anti-inflammatory and analgesic effects.

Special instructions

The duration of use of the drug Lorotox® is no more than 10 days, after which the prescribed treatment should be reconsidered.
When using Lorotox® in combination with other ear drops, it is necessary to maintain an interval of at least 30 minutes between instillations.

Information for athletes: the drug contains an active component that can give a positive reaction during doping control.
Read the instructions carefully before you start using the drug. Save the instructions, you may need them again. If you have any questions, consult your doctor.

Impact on the ability to drive vehicles and machinery

The drug does not affect the ability to drive a vehicle or work with complex machinery, machines or any other complex equipment that requires increased attention.

Active ingredient

Lidocaine, Phenazone

Composition

1 g of the drug contains:

Active ingredients:
Lidocaine hydrochloride monohydrate
10.7 mg
in terms of lidocaine hydrochloride
10.0 mg
Phenazone
40.0 mg
Excipients:
Ethanol 95%
221.8 mg
Water for injections
18.2 mg
Sodium thiosulfate pentahydrate
1.0 mg
1 M sodium hydroxide solution
up to pH 5.0-7.5
Glycerol anhydrous
up to 1.0 g

Contraindications

hypersensitivity to the components of the drug;
perforation of the eardrum (including infectious or traumatic origin);
hypersensitivity to pyrazolone derivatives (medicines containing metamizole sodium, phenylbutazone).
With caution

It is necessary to ensure the integrity of the eardrum before starting to use the drug. If the drug is used with a perforated eardrum, the drug may come into contact with the organs of the middle ear and lead to complications.

Side Effects

There is a risk of local allergic reactions, irritation and hyperemia of the ear canal.

Recommendations for use

Locally.

Storage conditions

Store at a temperature not exceeding 25 °C.

Shelf life

3 years.

Manufacturer

Grotex LLC, Russia